Expression and endocytosis of lysosomal aspartylglucosaminidase in mouse primary neurons

Journal of Neuroscience

Volumn 18, Issue 19, 1998, Pages 7750-7756

  Kyttälä, Aija ^a   Heinonen, Outi ^a   Peltonen, Leena ^a   Jalanko, Anu ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Aspartylglucosaminidase; Aspartylglucosaminuria; Lysosomal enzyme; Mannose 6 phosphate receptor; Mouse; Primary neurons

Indexed keywords

N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE;

ANIMAL CELL; ARTICLE; ASPARTYLGLYCOSAMINURIA; DEGENERATIVE DISEASE; ENDOCYTOSIS; ENZYME DEFECT; ENZYME SYNTHESIS; GENE MUTATION; LYSOSOME STORAGE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0032190248     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-19-07750.1998     Document Type: Article

References (10)

1. Amano T, Richelson E, Niremberg M (1972) Neurotransmitter synthesis by neuroblastoma clones. Proc Natl Acad Sci USA 69:258-263.
2. Aula P, Autio S, Raivio K, Rapola J (1982) Aspartylglucosaminuria. In: Genetic errors of glycoprotein metabolism, pp 123-152. Berlin: Springer.
3. Autio S, Visakorpi J, Järvinen H (1973) Aspartylglucosaminuria (AGU). Further aspects on its clinical picture, mode of inheritance and epidemiology based on a series of 57 patients. Ann Clin Res 5:149-155.
4. Autti T, Raininko R, Haltia M, Lauronen L, Vanhanen SL, Salonen O, Aronen HJ, Wirtavuori K, Santavuori P (1997) Aspartylglucosaminuria: Radiologic course of the disease with histopathologic correlation. J Child Neurol 12:369-375.
5. Enomaa N, Heiskanen T, Halila R, Sormunen R, Seppälä R, Vihinen M, Peltonen L (1992) Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts. Biochem J 286:613-618.
6. Enomaa N, Lukinmaa P-L, Ikonen E, Waltimo J, Palotie A, Paetau A, Peltonen L (1993) Expression of aspartylglucosaminidase in human tissues from normal individuals and aspartylglucosaminuria patients. J Histochem Cytochem 41:981-989.
7. Enomaa N, Danos O, Peltonen L, Jalanko A (1995) Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer. Hum Gene Ther 6:723-731.
8. Kennedy D, Abkowitz J (1997) Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90:986-993.
9. Kiess W, Blickenstaff G, Sklar M, Thomas S, Nissley P, Sahagian G (1988) Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose-6-phosphate receptor. J Biol Chem 263:9339-9344.
10. Krall W, Challita P, Perlmutter L, Skelton D, Kohn D (1994) Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83:2737-2748.